The U.S. stock market is effectively at all-time highs. Some investors are cautious, while other investors remain quite bullish. So, what happens when Wall Street analysts are calling on the gains to continue throughout 2026 and into 2027? This is when nimble investors need to pay close attention to their overall positions and portfolios. The S&P 500 was last seen with a 9% gain so far in 2026, and Wall Street still sees many notable stocks surging to even greater all-time highs in their 12-month outlooks.
Oggonomics tracks the flow of daily analyst upgrades, downgrades and initiations to find new ideas and overlooked opportunities for long-term investors and short-term traders alike. While no single analyst report should ever be the sole basis to buy or sell a stock, there are some interesting analyst upgrades from the week of June 5, 2026 that merit deeper reviews with impressive upside to analyst price targets.
Investors need to keep in mind that analysts can also get their thesis wrong. Company and market fundamentals can change in an instant. Investors should always know that no research report ever comes with money-back guarantees in the event of losses and come with no assurances that price expectations will ever be achieved. And never forget one prime mantra of Oggonomics — Always a bull, you’re a fool! Always a bear, you’re broke!
These were the top analyst upgrades seen for the week of June 5, 2026.
5 BIG ANALYST UPGRADES TO WATCH
Marriott Vacations Worldwide Corporation (NYSE: VAC) was given a rare double-upgrade at Goldman Sachs on June 1, raising its prior Sell rating to Buy and hiking its price target up to $100 from $70 (versus a prior $84.88 close) in the call. Goldman Sachs sees $VAC as one of the more compelling self-help stories in leisure and lifestyle, with earnings upside and a more constructive view on timeshares with strong travel demand.
Marriott Vacations closed up 6.8% at $90.67 on the day of the call, but it had pulled back to under $87 later in the week. Its 52-week range is $44.58 to $91.61 with a 3.6% dividend yield, and the consensus analyst price target was $87. Goldman Sachs has it as the best call in the timeshare sector after this upgrade, and the firm did not likely ask Chuck McDowell of Wesley Financial for permission in the upgrade.
RTX Corporation (NYSE: RTX) should be in the cat-bird seat for massive defense and commercial orders in its backlog, but the stock has been weak in 2026. Jefferies upgraded RTX to Buy from Hold and raised its price target to $220 from $210 in its June 4 call. The analyst sees a reasonable annualized 7% revenue growth target out to 2028 and raised earnings (per share) growth by 5% out to 2028 as well. Jefferies further noted that RTX is now able to take advantage of being in a hot section of the market in defense orders.
At the end of Q1-2026, RTX’s backlog of $271 billion equated to more than three years’ worth of orders and included $162 billion of commercial orders and $109 billion of defense orders. RTX closed up 3.9% at $179.51, making this the highest close since April and setting us a technical recovery off a range-bound base at the lows of the year. RTX has a 52-week range of $135.43 – $214.50 and its consensus analyst price target is $215.25.
Tesla Inc. (NASDAQ: TSLA) was upgraded to Neutral from Underweight by JPMorgan on June 5. While not a “buy” rating due to valuation, this is the first time JPMorgan hasn’t had the equivalent of a “Sell” rating in about 3 years. Also important is that the firm’s prior price target of $145 has now been raised to $475. This upgrade will significantly boost the previous consensus analyst price target (previously $395 on Finviz and $412 on Yahoo!Finance) when systems adjust for new price targets. JPMorgan analyst Rajat Gupta recently assumed coverage for the firm, replacing Ryan Brinkman as the firm’s perma-bear who previously had one of Wall Street’s lowest price targets.
Gupta cited that Tesla is at the forefront of physical AI and said that Musk & Co. is entering uncharted addressable markets, with a unique advantage and unmatched on an industrial-level scale — as well as efficacy and speed of its technology development. While the analyst sees Tesla trading at nearly 200-times next year’s earnings estimate, the earnings per share estimates of $3.15 in 2028 and $7.50 per share by 2030 implies more growth ahead. The stock traded lower in the broad technology sell-off on Friday, and Tesla’s stock has a 52-week range of $273.21 to $498.83.
ALSO READ: 5 Stocks to Beat Inflation and Boost Your Retirement Income
UnitedHealth (NYSE: UNH) was raised to Buy from Neutral and the price objective was raised to $450 from $420 at BofA Securities (June 5). The firm cited that UnitedHealth’s strong first quarter was not just a function of weak flu and storms, and that this should lead to a larger sector rally in managed care stocks if industry utilization trends continue to moderate. The firm also cited better medical cost trends look favorable for the second quarter earnings report as well. UnitedHealth closed up over 5.1% at $396.47 after the call, and the intraday high of $401.38 was less than 1% of its $404.15 high in the last 52-weeks.
Yum! Brands (NYSE: YUM) was upgraded to Overweight from Equal-Weight at Morgan Stanley on June 3, with the firm raising its price target to $185 from $180 in the call. The call is ahead of the likely divestiture of Pizza Hut from its KFC and Taco Bell brands. Morgan Stanley noted continued market-share gains and appeal to value-conscious consumers for Taco Bell, while pointing out that KFC’s international business keeps expanding as a second major growth engine. Yum! Brands’ stock was at $148 late in the week. Its 52-week range is $137.33 – $169.39 and its consensus analyst price target is $174.
TWO MORE WORTH NOTING
Two runner-up calls were not formal rating upgrades, but the stocks were added to the prized Goldman Sachs Conviction Buy list on June 1:
- TPG Inc. (NYSE: TPG) was reiterated as Buy with a $61 price target, versus a 52-week range of $36.95 to $70.38 and a consensus analyst price target of $57. The “conviction” call comes as TPG shares are down close to 40% YTD despite strong growth expectations ahead and a dividend above 5%. Investors may want to take note that Goldman Sachs had a $80 price target earlier in 2026, before broad bases concerns about private credit and private equity firms. This alternative asset manager claims $306 billion under management in multiple sectors. It also invests in private equity funds, real estate funds, hedge funds, and credit funds.
- Tyson Foods (NYSE: TSN) has a Buy rating and a $81 price target; and it is against a 52-week range of $50.56 – $69.48 and a consensus price target of $71. Tyson Foods traded lower after the call, trading at $57.00 late in the week. The firm sees its diversified protein portfolio and margin expansion helping a stock that is down over 40% from its 5-year peak above $90.
THE NON-ANALYST UPGRADE NOT TO MISS
Jensen Huang, CEO of NVIDIA ($NVDA) is not an analyst by any means, but he is CEO of the world’s largest company and commands an audience any time he makes forecasts. Huang called Marvell Technology, Inc. (NASDAQ: MRVL) out at Computex 2026 as the next $1 trillion company in a rare outlook (with no timeline included). Marvell shares were at $219.43 ahead of his keynote but surged to $290.79 after his remarks. The stock was then up to $316.43 later in the week with a $276 billion market cap, prior to its shares falling 6% to $297.00 early on Friday morning.
Here is what investors should be asking — Does this $1 trillion value imply that Jensen Huang sees Marvell shares rising to over $1,100 ahead? And what would that translate to in equity valuation terms? Be advised that the consensus analyst forecasts are projecting revenues of $11.5 billion in 2027 and $16.7 billion in 2028, after generating $8.2 billion in sales in its prior year. Huang cited Marvell’s critical role in AI data center connectivity, and Marvell is a strategic partner with a $2 billion investment from NVIDIA. Again, this forecast came with no timeline.
